Oliver Fiehn Selected Research

Lys(8)- oxytocin (OXL)

2/2022	Plasma Oxylipin Profile Discriminates Ethnicities in Subjects with Non-Alcoholic Steatohepatitis: An Exploratory Analysis.
1/2020	Impact of a weight loss and fitness intervention on exercise-associated plasma oxylipin patterns in obese, insulin-resistant, sedentary women.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Oliver Fiehn Research Topics

Disease

43	Neoplasms (Cancer) 02/2024 - 09/2008
23	Inflammation (Inflammations) 03/2024 - 06/2011
16	Cardiovascular Diseases (Cardiovascular Disease) 03/2024 - 01/2012
15	Insulin Resistance 06/2021 - 03/2010
11	Obesity 10/2023 - 02/2015
10	Breast Neoplasms (Breast Cancer) 01/2023 - 05/2011
9	Hypertension (High Blood Pressure) 01/2024 - 01/2013
8	Type 2 Diabetes Mellitus (MODY) 08/2023 - 01/2015
7	Adenocarcinoma 01/2022 - 05/2015
5	Lung Neoplasms (Lung Cancer) 01/2021 - 11/2015
5	Liver Diseases (Liver Disease) 12/2020 - 07/2012
5	Weight Loss (Weight Reduction) 01/2020 - 01/2014
4	Thrombosis (Thrombus) 11/2023 - 01/2018
4	Infections 11/2023 - 05/2012
4	Dyslipidemias (Dyslipidemia) 08/2023 - 01/2020
4	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 02/2023 - 01/2020
4	Carcinoma (Carcinomatosis) 01/2023 - 09/2008
4	Asthma (Bronchial Asthma) 01/2023 - 05/2015
4	Non-alcoholic Fatty Liver Disease 05/2022 - 01/2017
4	Hypoxia (Hypoxemia) 01/2021 - 01/2014
3	Atherosclerosis 10/2023 - 10/2008
3	Ovarian Neoplasms (Ovarian Cancer) 01/2023 - 01/2019
3	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2019
3	Pain (Aches) 01/2023 - 01/2020
3	Fatty Liver 01/2021 - 10/2017
3	Triple Negative Breast Neoplasms 01/2021 - 01/2016
3	Starvation 01/2020 - 12/2005
3	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 06/2013
3	Adenocarcinoma of Lung 01/2017 - 11/2015
3	Body Weight (Weight, Body) 01/2017 - 01/2014
2	Parkinson Disease (Parkinson's Disease) 05/2024 - 09/2023
2	Neuroinflammatory Diseases 03/2024 - 06/2012
2	Liver Neoplasms (Liver Cancer) 02/2024 - 01/2023
2	Birth Weight (Birth Weights) 11/2023 - 12/2021
2	Glioblastoma (Glioblastoma Multiforme) 08/2023 - 02/2023
2	Myocardial Infarction 01/2023 - 01/2020
2	Stroke (Strokes) 01/2023 - 01/2020
2	Chronic Pain 01/2023 - 01/2022

Drug/Important Bio-Agent (IBA)

47	LipidsIBA 03/2024 - 09/2008
27	Biomarkers (Surrogate Marker)IBA 05/2024 - 01/2010
18	Proteins (Proteins, Gene)FDA Link 11/2023 - 03/2007
16	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 04/2011
12	Amino Acids FDA Link 01/2022 - 09/2008
11	Fatty Acids (Saturated Fatty Acids)IBA 11/2023 - 03/2010
10	Phosphatidylcholines (Phosphatidylcholine)IBA 11/2023 - 05/2011
9	Triglycerides (Triacylglycerol)IBA 03/2024 - 02/2012
9	EnzymesIBA 01/2023 - 02/2012
8	OxylipinsIBA 02/2023 - 10/2017
8	Insulin (Novolin)FDA Link 06/2021 - 05/2011
7	CeramidesIBA 03/2024 - 12/2014
7	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2023 - 06/2015
6	SphingomyelinsIBA 03/2024 - 12/2014
6	Glutamic Acid (Glutamate)FDA Link 01/2023 - 12/2013
5	Cholesterol Esters (Cholesteryl Esters)IBA 11/2023 - 01/2017
5	Phospholipids (Phosphatides)FDA LinkGeneric 01/2023 - 05/2011
5	Estrogen ReceptorsIBA 01/2021 - 05/2011
4	CholesterolIBA 03/2024 - 01/2016
4	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 11/2023 - 06/2015
4	MicroRNAs (MicroRNA)IBA 01/2023 - 10/2017
4	AcidsIBA 01/2023 - 04/2014
4	Glutamine (L-Glutamine)FDA Link 01/2023 - 12/2013
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 08/2022 - 01/2017
4	Methionine (L-Methionine)FDA Link 01/2022 - 06/2015
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2019 - 01/2012
4	CarbonIBA 08/2019 - 10/2012
4	Branched-Chain Amino AcidsIBA 04/2017 - 07/2014
3	LDL CholesterolIBA 01/2024 - 01/2012
3	IsotopesIBA 08/2023 - 01/2018
3	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 08/2023 - 02/2016
3	oxidized low density lipoproteinIBA 08/2023 - 01/2017
3	Docosahexaenoic AcidsIBA 01/2023 - 01/2021
3	Glycerophospholipids (Phosphoglycerides)IBA 01/2023 - 11/2022
3	Arachidonic Acid (Vitamin F)IBA 01/2023 - 06/2015
3	AntioxidantsIBA 05/2022 - 05/2015
3	PolyaminesIBA 03/2022 - 01/2017
3	EndocannabinoidsIBA 02/2022 - 01/2020
3	Epoxide HydrolasesIBA 01/2022 - 10/2008
3	Arginine (L-Arginine)FDA Link 06/2021 - 05/2015
3	CytokinesIBA 06/2021 - 05/2015
3	AutoantibodiesIBA 01/2021 - 06/2012
3	Choline (Choline Chloride)IBA 01/2021 - 01/2018
3	alpha-Linolenic Acid (Linolenic Acid)IBA 01/2021 - 10/2017
3	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2021 - 06/2011
3	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2021 - 07/2012
3	Interleukin-8 (Interleukin 8)IBA 01/2021 - 06/2011
3	Bile Acids and Salts (Bile Acids)IBA 01/2020 - 08/2016
3	trimethyloxamine (trimethylamine N-oxide)IBA 01/2018 - 07/2015
3	Ketoglutaric Acids (Ketoglutaric Acid)IBA 01/2017 - 01/2014
2	Niacin (Nicotinic Acid)FDA LinkGeneric 03/2024 - 02/2024
2	phosphatidylethanolamineIBA 03/2024 - 03/2016
2	omega-Chloroacetophenone (Mace)IBA 02/2024 - 01/2023
2	Biogenic Amines (Biogenic Amine)IBA 08/2023 - 01/2019
2	Ether (Diethyl Ether)IBA 01/2023 - 01/2022
2	ZincIBA 01/2023 - 10/2017
2	Protein Isoforms (Isoforms)IBA 01/2023 - 01/2022
2	SphingolipidsIBA 01/2023 - 11/2022
2	AcyltransferasesIBA 01/2023 - 02/2012
2	Proline (L-Proline)FDA Link 11/2022 - 06/2019
2	Lys(8)- oxytocin (OXL)IBA 02/2022 - 01/2020

Therapy/Procedure

11	Therapeutics 05/2024 - 11/2006